CareDx and Leading Transplant Clinicians to Present AlloSure® DART Data During Kidney Week at the American … GlobeNewswire (press release) BRISBANE, Calif., Nov. 16, 2016 (GLOBE NEWSWIRE) — CareDx, Inc. (Nasdaq:CDNA), a molecular diagnostics company focused on the discovery, development and commercialization of clinically differentiated, high-value diagnostic solutions for transplant …
top of page
Search
Recent Posts
See AllMay 27, 2017 A new study indicates that receiving donor kidneys from individuals with diabetes may offer a greater survival benefit than remaining on the waitlist for many transplant candidates. The f
bottom of page